<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03745560</url>
  </required_header>
  <id_info>
    <org_study_id>1111/2017</org_study_id>
    <nct_id>NCT03745560</nct_id>
  </id_info>
  <brief_title>Intraoperative EABR for Decision Making</brief_title>
  <official_title>Simultaneous Translabyrinthine Surgery of Vestibular Schwannoma and Cochlear Implantation With Intraoperative eBERA and Correlation to Hearing Results - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Christoph Arnoldner</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study patients undergoing simultaneous translabyrinthine vestibular schwannoma
      resection and cochlear implantation are included. The goal of the study is to correlate the
      eABR results with postoperative hearing results.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing translabyrinthine vestibular schwannoma resection are included in the
      study. Preoperatively an eABR is carried out, as well as before and after tumor resection.

      Postoperatively patients are fitted with a cochlear implant as routinely carried out. The
      postoperative hearing results with cochlear implant are correlated to the eABR results. The
      study is an observational study since eABR measurements are not part of the study. A
      correlation between eABR results categorized in three groups (good response, weak response,
      no response) with monosyllable understanding with cochlear implant (measured with Freiburger
      monosyllables test).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 23, 2017</start_date>
  <completion_date type="Anticipated">May 23, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 23, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of eABR results to postoperative hearing results</measure>
    <time_frame>2 years</time_frame>
    <description>eABR is correlated with postoperative hearing results eABR will be divided in three categories - good response, weak response, no response.
Hearing results will be measured with speech understanding in Freiburg monosyllables word test which is measured in % of monosyllables understanding at 65 and 80dB</description>
  </primary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Vestibular Schwannoma</condition>
  <condition>Hearing Loss</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing translabyrinthine vestibular schwannoma resection and cochlear
        implantation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 18 and 99 years undergoing translabyrinthine vestibular schwannoma
             resection

          -  Patients wanted hearing rehabilitation with a cochlear implant

        Exclusion Criteria:

          -  patients who do not want to be part of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Arnoldner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MUW, Allgemeines Krankenhaus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valerie Dahm</last_name>
    <phone>01/40400/33300</phone>
    <email>valerie.dahm@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>AKH, MUW</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Dahm, MD</last_name>
      <phone>004314040033300</phone>
      <email>valerie.dahm@meduniwien.ac.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 3, 2018</study_first_submitted>
  <study_first_submitted_qc>November 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2018</study_first_posted>
  <last_update_submitted>December 30, 2019</last_update_submitted>
  <last_update_submitted_qc>December 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Christoph Arnoldner</investigator_full_name>
    <investigator_title>Assoc. Prof PD. Dr.</investigator_title>
  </responsible_party>
  <keyword>Cochlear implant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurilemmoma</mesh_term>
    <mesh_term>Neuroma, Acoustic</mesh_term>
    <mesh_term>Hearing Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

